Related Experiment Video
Updated: Feb 17, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Emerging roles for long noncoding RNAs in B-cell development and malignancy
M Winkle1, J L Kluiver1, A Diepstra1
1Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Long noncoding RNAs (lncRNAs) are crucial in B-cell development and cancer. Their dysregulation in B-cell malignancies highlights their role in oncogenic pathways and therapeutic response, making them potential biomarkers.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Biology
Background:
- Long noncoding RNAs (lncRNAs) are key regulators of cellular processes, including differentiation and cancer.
- Aberrant lncRNA expression is linked to cancer hallmarks and offers potential for targeted therapies.
- lncRNAs exhibit tissue- and cell-type specificity, making them attractive biomarkers and prognostic factors.
Purpose of the Study:
- To review lncRNA expression changes during normal B-cell development.
- To investigate lncRNA deregulation in B-cell malignancies.
- To explore the prognostic value and molecular functions of deregulated lncRNAs in B-cell cancers.
Main Methods:
- Literature review of studies on lncRNA expression in B-cell development and malignancies.
- Analysis of lncRNA functions at transcriptional, posttranscriptional, and protein levels.
- Evaluation of the prognostic significance and therapeutic implications of lncRNAs.
Main Results:
- lncRNAs play essential roles in normal B-cell differentiation.
- lncRNA deregulation is prevalent in B-cell malignancies.
- Specific lncRNAs are implicated in oncogenic pathways and influence therapeutic responses.
Conclusions:
- lncRNAs are major players in both normal and malignant B cells.
- Dysregulated lncRNAs contribute to cancer development and progression.
- lncRNAs hold promise as biomarkers and therapeutic targets in B-cell cancers.
More Related Videos
10:26In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Cells of the Adaptive Immune Response
RNA Splicing
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...